Smoking and nasopharyngeal cancer: individual data meta-analysis of six prospective studies on 334 935 men. (31st March 2021)

• Record Type: Journal Article
• Authors: Lin, Jia Huang; Wen, Chi Pang; Jiang, Chao Qiang; Yuan, Jian-Min; Chen, Chien Jen; Ho, Sai Yin; Gao, Wayne; Zhang, Weisen; Wang, Renwei; Chien, Yin-Chu; Xu, Lin; Wu, Xifeng; Jin, Ya Li; Koh, Woon-Puay; Hsu, Wan-Lun; Zhu, Feng; Wen, Christopher; Zhu, Tong; Lee, June Han; Mai, Zhi-Ming; Lung, Maria Li; Lam, Tai-Hing
• Is Part Of: International journal of epidemiology. Volume 50:Number 3(2021)
• Page Start: 975
• Page End: 986
• Publication Date: 2021-03-31
• Subjects: Nasopharyngeal carcinoma -- smoking -- epidemiology -- cohort study -- individual data -- meta-analysis; Epidemiology -- Periodicals; 614.4
• DOI: 10.1093/ije/dyab060
• Languages: English
• ISSNs: 0300-5771

Abstract

Abstract: Background: The role of smoking in nasopharyngeal carcinoma (NPC) remains uncertain, especially in endemic regions. We conducted an individual participant data (IPD) meta-analysis of prospective cohort studies to investigate the associations between smoking exposure and risk of NPC. Methods: We obtained individual participant data of 334 935 male participants from six eligible population-based cohorts in NPC-endemic regions, including two each in Guangzhou and Taiwan, and one each in Hong Kong and Singapore. We used one- and two-stage approaches IPD meta-analysis and Cox proportional hazard models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of NPC for smoking exposure adjusting for age and drinking status. Results: During 2 961 315 person-years of follow-up, 399 NPC evens were ascertained. Risks of NPC were higher in ever versus never smokers (HRone-stage = 1.32, 95% CI = 1.07-1.63, P = 0.0088; HRtwo-stage = 1.27, 1.01-1.60, 0.04). These positive associations appeared to be stronger in ever smokers who consumed 16+ cigarettes/day (HRone-stage = 1.67, 95% CI = 1.29-2.16, P = 0.0001), and in those who started smoking at age younger than 16 (2.16, 1.33-3.50, 0.0103), with dose-response relationships ( P -values for trend = 0.0028 and 0.0103, respectively). Quitting (versus daily smoking) showed a small reduced risk (stopped for 5+ years: HRone-stage = 0.91, 95% CI = 0.60-1.39, P = 0.66; for former smokers: HRtwo-stage = 0.84, 0.61-1.14, 0.26). Conclusions: This first IPD meta-analysis from six prospective cohorts in endemic regions has provided robust observational evidence that smoking increased NPC risk in men. NPC should be added to the 12–16 cancer sites known to be tobacco-related cancers. Strong tobacco control policies, preventing young individuals from smoking, would reduce NPC risk in endemic regions.